Gong-rak Lee
Seoul, Republic of Korea
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 11 publications
LMT328, a sulfiredoxin inhibitor, induces preferential cancer cell death and tumor regression via oxidative stress.
Journal: Free radical biology & medicine
Published: March 26, 2026
Rgnef regulates bone mass through the activation of RhoA and Rac1.
Journal: Experimental & molecular medicine
Published: February 25, 2025
Cholesterol sulfate inhibits osteoclast differentiation and survival by regulating the AMPK-Sirt1-NF-κB pathway.
Journal: Journal of cellular physiology
Published: November 29, 2022
Dynein light chain LC8 alleviates nonalcoholic steatohepatitis by inhibiting NF-κB signaling and reducing oxidative stress.
Journal: Journal of cellular physiology
Published: December 27, 2021
Flunarizine inhibits osteoclastogenesis by regulating calcium signaling and promotes osteogenesis.
Journal: Journal of cellular physiology
Published: January 06, 2021
Cinchonine inhibits osteoclast differentiation by regulating TAK1 and AKT, and promotes osteogenesis.
Journal: Journal of cellular physiology
Published: March 09, 2020
Benzydamine inhibits osteoclast differentiation and bone resorption via down-regulation of interleukin-1 β expression.
Journal: Acta pharmaceutica Sinica. B
Published: March 04, 2019
Euphorbia factor L1 inhibits osteoclastogenesis by regulating cellular redox status and induces Fas-mediated apoptosis in osteoclast.
Journal: Free radical biology & medicine
Published: February 10, 2017
Effective killing of cancer cells and regression of tumor growth by K27 targeting sulfiredoxin.
Journal: Free radical biology & medicine
Published: February 29, 2016
Sulfiredoxin inhibitor induces preferential death of cancer cells through reactive oxygen species-mediated mitochondrial damage.
Journal: Free radical biology & medicine
Published: August 10, 2015
Showing 1-11 of 11
Last Updated: 09/26/2026